Leuprolide Acetate Market Size & Share, by Product (Vials, Prefilled Syringes, Lyophilized Powder); Application (Cancer, Endometriosis, Radical Prostatectomy, Hormone Therapy, Central Precocious Puberty, Uterine Fibroids); Route of Administration (Intradermal, Intramuscular, Subcutaneous); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5156
  • Published Date: Aug 11, 2023
  • Report Format: PDF, PPT

Companies Dominating the Leuprolide Acetate Market

    • Ferring B.V.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Sun Pharmaceutical Industries Ltd.
    • Beijing Biote Pharmaceutical Co., Ltd.
    • Anhui Anke Bioengineering (Group) Co., Ltd.
    • AbbVie Inc.
    • Merck & Co., Inc.
    • Taj Pharmaceuticals Limited.
    • Zydus Group
    • Cipla Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Eugia Pharma Specialties Limited received approval from the US Food and Drug Administration (USFDA) to produce and sell injectable leuprolide acetate which is employed to treat the symptoms of advanced prostate cancer.
  • Cipla Inc. introduced Leuprolide Acetate Injection Depot 22.5mg to offer patients in the US high-quality, inexpensive treatments, and enable access to top-notch therapies. Further, it is provided as lyophilized microspheres in a single dose vial as part of a kit that also includes MIXJECT transfer device and a prefilled syringe.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5156
  • Published Date: Aug 11, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing cases of cancer across the globe and the growing prevalence of uterus fibroids are the major factors driving the growth of the market.

The market size of Leuprolide Acetate is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023 – 2035.

The major players in the market are AbbVie Inc., Merck & Co., Inc., Taj Pharmaceuticals Limited., Zydus Group, Cipla Inc., Eugia Pharma, Sumitomo Dainippon Pharma, Kyowa Kirin, Takeda Pharmaceutical Company Limited.

The prefilled syringes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying